高果糖摄入导致肝脏尿酸代谢紊乱并促进非酒精性脂肪性肝病的机制研究
批准号:
82070585
项目类别:
面上项目
资助金额:
56.0 万元
负责人:
徐承富
依托单位:
学科分类:
肝脏代谢障碍及相关疾病
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
徐承富
中文摘要
非酒精性脂肪性肝病(NAFLD)是临床常见且危害巨大的慢性肝病,其发病机制尚未完全明确。肝脏是果糖代谢和尿酸生成的主要器官,已有研究证实高果糖摄入显著增加肝脏尿酸生成并升高NAFLD发病风险。本团队前期系列研究发现高尿酸是引发NAFLD的重要原因。然而,高果糖摄入如何导致肝脏尿酸代谢紊乱并促进NAFLD发生发展仍不清楚。本项目拟在已有基础上,建立高果糖诱导的NAFLD细胞和小鼠模型并结合基因敲除小鼠,深入揭示高果糖如何通过果糖代谢关键酶KHK与尿酸合成限速酶XO依赖途径调节肝脏尿酸代谢,并进一步揭示高尿酸对ChREBP与SREBP1c及其下游的ACC1、FAS、SCD1等脂肪酸合成关键分子的影响,对NADPH氧化酶及ROS生成和NLRP3炎症小体激活的影响,对MCP-1表达和肝脏巨噬细胞浸润的调控作用。本项目预期结果将从尿酸代谢角度揭示高果糖引发NAFLD的新机制,为疾病防治提供新思路。
英文摘要
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver disease with significant clinical importance. The pathogenesis of NAFLD remains unclear. Liver is the major organ involved in fructose metabolism and uric acid production. Recent literatures have repeatedly reported that high fructose consumption significantly increased risk of NAFLD, accompanied with increased hepatic uric acid production, which resulted in hyperuricemia. We previously found that hyperuricemia is a major pathogenic factor for NAFLD, based on the evidence that hyperuricemia directly induced hepatocyte fat accumulation both in vitro and in vivo. However, the regulatory mechanisms of high fructose consumption on hepatic uric acid metabolism and NAFLD remains poorly understood. In this study, we are going to establish high-fructose induced cellular and mouse models of NAFLD, as well as gene knockout mouse models. The interactions between hepatic fructose metabolism and uric acid production will be investigated by means of manipulation of the key enzymes fructokinase and xanthine oxidase. The regulatory effects of uric acid on the expressions of transcription factors ChREBP and SREBP1c, and their downstream genes involved in de novo lipogenesis including ACC1, FAS, and SCD1 will be investigated. The regulatory effects of uric acid on NADPH oxidase, ROS production, NLRP3 inflammasome activation, as well as the regulatory role of uric acid on hepatic MCP-1 expression and macrophage infiltration will also be studied. The results of this study will expand our understanding of the mechanisms by which high fructose consumption induces hyperuricemia and NAFLD, and may help the development of novel therapeutics for NAFLD.
非酒精性脂肪性肝病(NAFLD)是临床常见且危害巨大的慢性肝病,其发病机制尚未完全明确。本团队前期研究发现高尿酸血症显著增加NAFLD发病风险,但具体机制仍有待阐明。本项目采用高脂饮食(HFD)、高果糖饮水联合西方饮食(WDSW)等方法建立了多种NAFLD小鼠模型,发现尿酸代谢关键酶——黄嘌呤氧化酶(XO)在上述NAFLD模型小鼠肝脏中表达显著上调,敲低XO显著减轻游离脂肪酸(FFA)诱导的肝细胞脂质沉积和炎症,过表达XO则观察到相反的现象。小鼠实验发现,肝细胞特异性敲除XO显著缓解NAFLD小鼠肝脏脂变程度、抑制小鼠肝脏脂质合成和炎症并改善胰岛素抵抗。代谢组学结果显示,肝脏特异性敲除XO后,HFD诱导的NAFLD模型小鼠肝脏共有45种代谢物显著上调、59种显著下调,其中α-亚麻酸代谢通路中的有益n-3多不饱和脂肪酸α-亚麻酸及其产物亚麻油酸的水平显著上升。转录组学分析及后续的验证结果显示,XO对SIRT1/mTOR通路具有调节作用;抑制SIRT1逆转了XO敲低对肝细胞脂变的改善作用,抑制SIRT1也逆转了肝脏特异性敲除XO对NAFLD小鼠的改善作用,表明SIRT1介导了XO对NAFLD的调节作用。本项目后续实验发现结晶状态的尿酸是介导肝损伤的主要尿酸形式,结晶状态的尿酸可诱导肝脏巨噬细胞浸润增加,促进肝损伤发生发展。本项目还依托NAFLD队列及标本库,通过前瞻性研究明确了高尿酸血症显著增加NAFLD患者远期死亡风险等不良结局,通过孟德尔随机化分析明确了饮食、代谢等可控危险因素与NAFLD患病风险密切相关,揭示了高含硫微生物饮食显著增加NAFLD发病风险。项目实施过程中,本项目组还受邀撰写NAFLD代谢机制相关综述。以上结果发表于Hepatology、Metabolism、Am J Clin Nutr、J Biol Chem等期刊,相关结果揭示了NAFLD发病新机制,并为疾病防治提供了潜在新方法。
高尿酸下调肝细胞线粒体HINT2并促进NASH的机制和干预策略研究
-
批准号:82370574
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:徐承富
-
依托单位:
尿酸对肝细胞miR-92a的调节作用及其影响NAFLD的分子机制研究
-
批准号:81770573
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2017
-
负责人:徐承富
-
依托单位:
Olfactomedin 4在非酒精性脂肪性肝病中的作用及机制研究
-
批准号:81470838
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:徐承富
-
依托单位:
黄嘌呤氧化还原酶XOR在非酒精性脂肪性肝病中的作用及机制研究
-
批准号:81100278
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:徐承富
-
依托单位:
国内基金
海外基金